Huons Global Co., Ltd. (KOSDAQ:084110)

South Korea flag South Korea · Delayed Price · Currency is KRW
63,200
+200 (0.32%)
At close: Feb 27, 2026
91.23%
Market Cap 771.23B
Revenue (ttm) 825.44B
Net Income (ttm) 24.39B
Shares Out 12.20M
EPS (ttm) 1,999.54
PE Ratio 31.61
Forward PE n/a
Dividend 880.00 (1.39%)
Ex-Dividend Date Apr 2, 2026
Volume 55,747
Average Volume 51,460
Open 62,300
Previous Close 63,000
Day's Range 60,300 - 63,200
52-Week Range 31,500 - 66,000
Beta 1.04
RSI 76.20
Earnings Date Feb 13, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami... [Read more]

Sector Healthcare
Founded 1965
Employees 118
Stock Exchange KOSDAQ
Ticker Symbol 084110
Full Company Profile

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.

Financial Statements

News

There is no news available yet.